BIOMAT Database Logo BIOMAT Database Logo

Phase II study of intravesical chemoprophylaxis of epirubicin after transurethral resection of bladder tumors. Tottori University Oncology Group. 1994

N Watanabe, and I Miyagawa, and Y Higasibori, and T Nakahara, and F Sumi, and G Ishida, and B Abe, and A Inoue, and N Hanamoto
Division of Urology, San-in Rosai Hospital, Tottori, Japan.

We performed intravesical instillation of epirubicin in 53 patients with the aim of preventing recurrence of bladder tumors. The patients had undergone transurethral resection of superficial bladder tumors (only transitional-cell carcinoma) within the preceding week, between January of 1990 and July of 1991. Recurrence was found in 11.3% (6/53) of cases during follow-up periods lasting from 1 to 20 months. Side effects occurred in 5.7% (3/53) of the patients. The cumulative nonrecurrence rate was 96.0% for a follow-up period of 6 months and 78.4% for 12 months. The results of this study suggest that intravesical instillation of epirubicin is very useful as adjuvant therapy after transurethral resection of superficial bladder tumors.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000283 Administration, Intravesical The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms. Bladder Drug Administration,Drug Administration, Bladder,Instillation, Bladder,Intravesical Drug Administration,Administration, Intravesical Drug,Injections, Intravesical,Intravesical Administration,Intravesical Injection,Intravesical Instillation,Administration, Bladder Drug,Administrations, Bladder Drug,Administrations, Intravesical,Administrations, Intravesical Drug,Bladder Drug Administrations,Bladder Instillation,Bladder Instillations,Drug Administration, Intravesical,Drug Administrations, Bladder,Drug Administrations, Intravesical,Injection, Intravesical,Instillation, Intravesical,Instillations, Bladder,Instillations, Intravesical,Intravesical Administrations,Intravesical Drug Administrations,Intravesical Injections,Intravesical Instillations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

N Watanabe, and I Miyagawa, and Y Higasibori, and T Nakahara, and F Sumi, and G Ishida, and B Abe, and A Inoue, and N Hanamoto
Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors.
January 1983, Cancer chemotherapy and pharmacology,
N Watanabe, and I Miyagawa, and Y Higasibori, and T Nakahara, and F Sumi, and G Ishida, and B Abe, and A Inoue, and N Hanamoto
Intravesical explosion during transurethral resection of bladder tumors.
November 2004, The Journal of urology,
N Watanabe, and I Miyagawa, and Y Higasibori, and T Nakahara, and F Sumi, and G Ishida, and B Abe, and A Inoue, and N Hanamoto
[A randomized study on intravesical pirarubicin (THP) chemoprophylaxis of recurrence after transurethral resection of superficial bladder cancer].
December 1997, Hinyokika kiyo. Acta urologica Japonica,
N Watanabe, and I Miyagawa, and Y Higasibori, and T Nakahara, and F Sumi, and G Ishida, and B Abe, and A Inoue, and N Hanamoto
[Continuous intravesical instillation of epirubicin immediately after transurethral resection of superficial bladder cancer: a prospective controlled study].
May 2000, Hinyokika kiyo. Acta urologica Japonica,
N Watanabe, and I Miyagawa, and Y Higasibori, and T Nakahara, and F Sumi, and G Ishida, and B Abe, and A Inoue, and N Hanamoto
Transurethral resection and intravesical therapy of superficial bladder tumors.
August 1991, The Urologic clinics of North America,
N Watanabe, and I Miyagawa, and Y Higasibori, and T Nakahara, and F Sumi, and G Ishida, and B Abe, and A Inoue, and N Hanamoto
Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection.
August 2004, BJU international,
N Watanabe, and I Miyagawa, and Y Higasibori, and T Nakahara, and F Sumi, and G Ishida, and B Abe, and A Inoue, and N Hanamoto
Perioperative intravesical therapy after transurethral resection for bladder cancer.
January 2010, The Journal of urology,
N Watanabe, and I Miyagawa, and Y Higasibori, and T Nakahara, and F Sumi, and G Ishida, and B Abe, and A Inoue, and N Hanamoto
A randomized study of short-versus long-term intravesical epirubicin instillation for superficial bladder cancer. Nagoya University Urological Oncology Group.
January 1998, European urology,
N Watanabe, and I Miyagawa, and Y Higasibori, and T Nakahara, and F Sumi, and G Ishida, and B Abe, and A Inoue, and N Hanamoto
A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences.
January 2008, The Journal of urology,
N Watanabe, and I Miyagawa, and Y Higasibori, and T Nakahara, and F Sumi, and G Ishida, and B Abe, and A Inoue, and N Hanamoto
Repeated transurethral resection and intravesical BCG for extensive superficial bladder tumors.
October 2001, Journal of endourology,
Copied contents to your clipboard!